Dr. Brivanlou heads TCW’s Income Equities group and is the Lead Portfolio Manager for the High Dividend, REIT, and Low Volatility suite of strategies. He is also a co-head of Q-Alpha, TCW’s Artificial Intelligence and Machine Learning (AI/ML) initiative, and is the the chair of TCW’s Proxy Committee. He joined TCW in 2006 as an Analyst in the Equity Research group. His research coverage has spanned the real estate, insurance, business services, transportation, and consumer staples sectors. Prior to TCW, he developed and tested quantitative models aimed at predicting the sizes of catalyst “events” using option pricing for Kayne Anderson, a hedge fund in Century City. He is involved in a number of philanthropic activities and serves on the L.A. Opera Board of Directors, a position that he has held since 2015. Dr. Brivanlou was a Howard Hughes post-doctoral fellow in Molecular Neurobiology at the Salk Institute in La Jolla. He holds a BS in Physics from Massachusetts Institute of Technology (MIT), a PhD in Computational Neuroscience from Harvard University, and an MBA in Finance and Strategy from the UCLA Anderson School of Management.